Citations for
1ATP2C1, TMEM165
SPCA1 governs the stability of TMEM165 in Hailey-Hailey disease
Roy AS, Miskinyte S, Garat A, Hovnanian A, Krzewinski-Recchi MA, Foulquier F.
Biochimie. Jul;174:159-170. doi: 10.1016/j.biochi.2020.04.017. Epub 2020 Apr 23. 2020
2TMEM165
Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma
Murali P, Johnson BP, Lu Z, Climer L, Scott DA, Foulquier F, Oprea-Ilies G, Lupashin V, Drake RR, Abbott KL.
Oncotarget. ul 14;11(28):2747-2762. doi: 10.18632/oncotarget.27668. 2020
3TMEM165
In Situ Fluorescent and Photoacoustic Imaging of Golgi pH to Elucidate the Function of Transmembrane Protein 165
Wang H, Yang Y, Huang F, He Z, Li P, Zhang W, Zhang W, Tang B.
Anal Chem. Feb 18;92(4):3103-3110. doi: 10.1021/acs.analchem.9b04709. Epub 2020 Feb 7. 2020
4ATP2C1, TMEM165
Investigating the functional link between TMEM165 and SPCA1
Lebredonchel E, Houdou M, Hoffmann HH, Kondratska K, Krzewinski MA, Vicogne D, Rice CM, Klein A, Foulquier F.
Biochem J. Nov 15;476(21):3281-3293. doi: 10.1042/BCJ20190488. 2019
5TMEM165
Dissection of TMEM165 function in Golgi glycosylation and its Mn2+ sensitivity.
Lebredonchel E, Houdou M, Potelle S, de Bettignies G, Schulz C, Krzewinski Recchi MA, Lupashin V, Legrand D, Klein A, Foulquier F.
Biochimie. Oct;165:123-130. doi: 10.1016/j.biochi.2019.07.016. Epub 2019 Jul 24. 2019
6TMEM165
TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activity.
Lee JS, Kim MY, Park ER, Shen YN, Jeon JY, Cho EH, Park SH, Han CJ, Choi DW, Jang JJ, Suh KS, Hong J, Kim SB, Lee KH
Oncol Rep. Sep;40(3):1297-1306. doi: 10.3892/or.2018.6565. Epub 2018 Jul 12. 2018
7CDG2K, TMEM165
TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis.
Dulary E, Potelle S, Legrand D, Foulquier F.
Tissue Cell. Apr;49(2 Pt A):150-156. doi: 10.1016/j.tice.2016.06.006. Epub 2016 Jun 16 2017
8TMEM165
Manganese-induced turnover of TMEM165
Potelle S, Dulary E, Climer L, Duvet S, Morelle W, Vicogne D, Lebredonchel E, Houdou M, Spriet C, Krzewinski-Recchi MA, Peanne R, Klein A, de Bettignies G, Morsomme P, Matthijs G, Marquardt T, Lupashin V, Foulquier F.
Biochem J. Apr 19;474(9):1481-1493. doi: 10.1042/BCJ20160910. 2017
9TMEM165
Molecular evolution of a novel family of putative calcium transporters
Demaegd D, Colinet AS, Deschamps A, Morsomme P.
PLoS One. Jun 23;9(6):e100851. doi: 10.1371/journal.pone.0100851. 2014
10CDG2K, TMEM165
Impact of disease-causing mutations on TMEM165 subcellular localization, a recently identified protein involved in CDG-II
Rosnoblet C, Legrand D, Demaegd D, Hacine-Gherbi H, de Bettignies G, Bammens R, Borrego C, Duvet S, Morsomme P, Matthijs G, Foulquier F.
Hum Mol Genet. Jul 15;22(14):2914-28. doi: 10.1093/hmg/ddt146. Epub 2013 Apr 10. 2013
11CDG2K, TMEM165
TMEM165 Deficiency Causes a Congenital Disorder of Glycosylation.
Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, Bammens R, Morelle W, Rosnoblet C, Legrand D, Demaegd D, Buist N, Cheillan D, Guffon N, Morsomme P, Annaert W, Freeze HH, Van Schaftingen E, Vikkula M, Matthijs G.
Am J Hum Genet 91(1):15-26. Epub 2012 Jun 7. 2012
12TMEM165
Messenger RNA expressed in mouse teratocarcinoma stem cells and down-regulated by a tumor-promoting phorbol ester codes for a novel transmembrane protein.
Akagi J, Nomiyama H, Setoyama C, Shimada K, Akagi M.
Biochem Biophys Res Commun 157(2):548-57. 1988